Gastric cancer treated in 2002 in Japan: 2009 annual report of the JGCA nationwide registry

Nashimoto, Atsushi; Akazawa, Kohei; Isobe, Yoh; Miyashiro, Isao; Katai, Hitoshi; Kodera, Yasuhiro; Tsujitani, Shunichi; Seto, Yasuyuki; Furukawa, Hiroshi; Oda, Ichiro; Ono, Hiroyuki; Tanabe, Satoshi; Kaminishi, Michio

doi:10.1007/s10120-012-0163-4

Cited by 415 publications

(291 citation statements)

References 3 publications

Supporting

Mentioning

274

Contrasting

Unclassified

Order By: Relevance

“…According to the JGCA data, cumulative 5-year survival of stage IV patients was 15.3%, 2 and Korean data also showed similar results with 18%. 3 Moreover, among all stage IV patients, 4% to 9% of them are said to be too advanced with no chance of curative surgery and their prognosis is absolutely poor showing less than 10% at 3 years after diagnosis.…”

Section: Discussionmentioning

confidence: 67%

See 1 more Smart Citation

Prognostic Factors for Stage IV Gastric Cancer

Baba

Kuwabara

Ishiguro

et al. 2013

International Surgery

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 67%

“…2 Therefore, we do not have a particular treatment algorithm against stage IV patients at this time. However, we weigh patients' clinical symptoms for decision making.…”

Section: Methodsmentioning

confidence: 99%

Prognostic Factors for Stage IV Gastric Cancer

Baba

Kuwabara

Ishiguro

et al. 2013

International Surgery

View full text Add to dashboard Cite

“…The 5‐year survival for patients with liver metastasis was 11.4% in Japanese GC patients 35. The median survival times of 3‐4 months after detection of bone metastasis have been reported in some studies36, 37 and the median survival after treatment of brain metastasis was about 3 months 23.…”

Section: Discussionmentioning

confidence: 93%

Frequency and clinicopathological features of metastasis to liver, lung, bone, and brain from gastric cancer: A SEER‐based study

et al. 2018

View full text Add to dashboard Cite

The hematogenous metastatic pattern of gastric cancer (GC) was not fully explored. Here we analyzed the frequency and clinicopathological features of metastasis to liver, lung, bone, and brain from GC patients. Data queried for this analysis included GC patients from the Surveillance, Epidemiology, and End Results Program database from 2010 to 2014. All of statistical analyses were performed using the Intercooled Stata 13.0 (Stata Corporation, College Station, TX). All statistical tests were two‐sided. Totally, there were 19 022 eligible patients for analysis. At the time of diagnosis, there were 7792 patients at stage IV, including 3218 (41.30%) patients with liver metastasis, 1126 (14.45%) with lung metastasis, 966 (12.40%) with bone metastasis and 151 (1.94%) with brain metastasis. GC patients with lung or liver metastasis have a higher risk of bone and brain metastasis than those without lung nor liver metastasis. Intestinal subtype had significantly higher rate of liver and lung metastasis, while diffuse type was more likely to have bone metastasis. Proximal stomach had significantly higher risk to develop metastasis than distal stomach. African‐Americans had the highest risk of liver metastasis and Caucasian had the highest prone to develop lung and brain metastasis. The median survival for patients with liver, lung, bone, and brain metastasis was 4 months, 3 months, 4 months and 3 months, respectively. It is important to evaluate the status of bone and brain metastasis in GC patients with lung or liver metastasis. Knowledge of metastatic patterns is helpful for clinicians to design personalized pretreatment imaging evaluation for GC patients.

show abstract

“…Albeit recent advancements in surgical techniques and perioperative care, the postoperative morbidity rate is as high as approximately 40% after esophageal cancer surgery,1, 2 and 20–30% after both gastric cancer surgery3, 4, 5 and colorectal surgery 6, 7, 8. Various reports have shown that such postoperative complications frequently reduce the overall survival (OS) as well as cancer‐specific survival after major surgery for cancer 9.…”

Section: Introductionmentioning

confidence: 99%

Does postoperative morbidity worsen the oncological outcome after radical surgery for gastrointestinal cancers? A systematic review of the literature

Shimada

Fukagawa

Haga

et al. 2017

Annals of Gastroent Surgery

104

View full text Add to dashboard Cite

PurposeThe impact of postoperative complications on survival after radical surgery for esophageal, gastric, and colorectal cancers remains controversial. We conducted a systematic review of recent publications to examine the effect of postoperative complications on oncological outcome.MethodsA literature search of PubMed/MEDLINE was performed using the keywords “esophageal cancer,” “gastric cancer,” and “colorectal cancer,” obtaining 27 reports published online up until the end of April 2016. Articles focusing on (i) postoperative morbidity and oncological outcome; and (ii) body mass index (BMI), postoperative morbidity, and oncological outcome, were selected. Univariate and multivariate analyses (Cox proportional hazards model) were performed.ResultsPatients with postoperative complications had significantly poorer long‐term survival than those without complications. Complications were associated with impaired oncological outcomes. The hazard ratios for overall survival were 1.67 (95% confidence interval [CI], 1.31‐2.12), 1.59 (95% CI, 1.13‐2.24), and 1.55 (95% CI, 1.28‐1.87) in esophageal, gastric, and colorectal cancers, respectively. High BMI was associated with postoperative morbidity rate but not with poor oncological outcome. Low BMI was significantly associated with inferior oncological outcome.ConclusionsComplications after radical surgery for esophageal, gastric, and colorectal cancers are associated with patient prognosis. Avoiding such complications might improve the outcomes.

show abstract

Gastric cancer treated in 2002 in Japan: 2009 annual report of the JGCA nationwide registry

Cited by 415 publications

References 3 publications

Prognostic Factors for Stage IV Gastric Cancer

Prognostic Factors for Stage IV Gastric Cancer

Frequency and clinicopathological features of metastasis to liver, lung, bone, and brain from gastric cancer: A SEER‐based study

Does postoperative morbidity worsen the oncological outcome after radical surgery for gastrointestinal cancers? A systematic review of the literature

Contact Info

Product

Resources

About